Status | Study |
Recruiting |
Study Name: Study of Mepolizumab Autoinjector in Asthmatics Condition: Asthma Date: 2017-03-29 Interventions: Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio |
Recruiting |
Study Name: A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma Condition: Eosinophils, Asthma Date: 2017-02-07 Interventions: Drug: reslizumab 110-mg |
Active, not recruiting |
Study Name: Study of Mepolizumab Safety Syringe in Asthmatics Condition: Asthma Date: 2017-01-12 Interventions: Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio |
Recruiting |
Study Name: An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation Condition: Asthma Date: 2016-10-14 Interventions: Drug: Reslizumab Administered |
Recruiting |
Study Name: European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank Condition: Lung Diseases, Interstitial Pulmonary Alveolar Proteinosis Date: 2016-07-29 |
Active, not recruiting |
Study Name: Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients Condition: Asthma Date: 2016-01-11 Interventions: Drug: Mepolizumab 100mg SC At |
Enrolling by invitation |
Study Name: Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma Condition: Severe Persistent Asthma Eosinophilic Bronchitis Date: 2015-09-22 Interventions: Biological: Reslizumab Reslizu |
Recruiting |
Study Name: Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients Condition: Asthma Date: 2015-09-17 Interventions: Biological: Mepolizumab 100mg |
Recruiting |
Study Name: Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma Condition: Severe Eosinophilic Asthma Date: 2015-09-04 Interventions: Drug: OC000459 Drug: Placebo |
Active, not recruiting |
Study Name: Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study Condition: Asthma Date: 2015-08-31 Interventions: Drug: Mepolizumab 100 mg SC ev |